In the present study, the water-soluble polysaccharides of Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii, were extracted and fractionated into four fractions of each material. The FT-IR and chemical analyses indicated the watersoluble polysaccharides of the three materials were all mainly composed of starch, non-starch type α-D-glucans and pectic polysaccharides with different molecular weight distributions and monosaccharide composition ratios. The antitumor assay showed that all the non-starch type polysaccharide fractions had good antitumor activities, and the tumor growth inhibition ratios were 37.24-70.42%. Specifically the inhibition ratios of pectic polysaccharides were over 60%. Moreover, the immunological tests using the Cyclophosphamide (Cy) induced immunosuppressive mice, including phagocytosis of macrophage, NK cell activity, concanavalin A (ConA)-induced T-cell proliferation, lipopolysaccharide (LPS)-induced B-cell proliferation, quantitative haemolysis of sheep red blood cells (SRBC) and dinitro-fluorobenzene (DNFB)-induced delayedtype hypersensitivity (DTH) response assays, exhibited that all the non-starch type polysaccharides, especially the pectic polysaccharide fractions, not only had remarkable immunostimulating activities including nonspecific immunity, cellular immunity and humoral immunity, but also could restore the antitumor drug-suppressed immune function. Therefore, the polysaccharides from Aconitum species might be conveniently exploited to be good immune stimulating modifiers and had the potential to apply in the tumor therapy.
Species of the genus Aconitum are the earliest recorded toxic plants, which have been used as arrow poisons and applied medicinally over the last 2500 years in China [1] . Radix Aconiti ("Chuanwu", the mother roots of Aconitum carmichaelii Debx.), Radix Aconiti Lateralis ("Fuzi", the daughter root of Aconitum carmichaelii Debx.) and Radix Aconiti Kusnezoffii ("Caowu", the mother roots of Aconitum Kusnezoffii Reichb.) are the most commonly used traditional Chinese medicines (TCM) of Aconitum species [2] , which are particularly valued as analgesic, anti-inflammatory (antirheumatic), antibiotic (antiseptic), antipyretic, cardiotonic, etc [3] .
For long time, the pharmacological studies were all focused on the low-molecular weight compounds, including diterpene alkaloids, isoquinoline alkaloids and amines [4] . Merely, Konno and Zhao isolated two α-(1→3),(1→6)-D-glucans from roots of A. carmichaelii Debx. and revealed the polysaccharides had hypoglycemic and lymphocyte proliferation activities [5] [6] [7] [8] .
To our knowledge, there is no comprehensive and systematic study on the polysaccharides from A. carmichaelii roots by now. Moreover, because of the different medicinal usages, looking Radix Aconiti and Radix Aconiti Lateralis as the same medicinal material was a mistake. With regard to Radix Aconiti Kusnezoffii, there is no report on the polysaccharides from it to date.
In present paper, the water-soluble polysaccharides from Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii were isolated, fractionated and used to do the compositions and pharmacological activities studies for exploiting a new sort of bioactive substances from genus Aconitum.
Each material was extracted by water at 4°C and 95°C in turn and the extracted polysaccharides were precipitated by ethanol. The collected polysaccharides were dissolved in water (5% w/v) to remove the insoluble substances originating from centrifugation. The supernatants were treated with Sevag reagent (1:4 n-butanol:chloroform, v/v) to remove proteins [9] . After removing the protein and Sevag reagent by centrifugation, the water phase was dialyzed against distilled water and lyophilized to yield the cold water extracted polysaccharides (CWP) and hot water extracted polysaccharides (HWP). Then the large amount of starch in CWP and HWP were removed by freeze-thawing process, generating non-starch type polysaccharide fractions CWPS and HWPS respectively. After separating the neutral and pectic polysaccharides by DEAE-Sepharose Fast Flow ionexchange chromatography, the water-soluble polysaccharides were finally fractionated into 4 fractions of each material: the fractions A-CWPS-N, A-CWPS-A, A-HWPS-N and A-HWPS-A were from Radix Aconiti; the fractions L-CWPS-N, L-CWPS-A, L-HWPS-N and L-HWPS-A were from Radix Aconiti Lateralis; the fractions K-CWPS-N, K-CWPS-A, K-HWPS-N and K-HWPS-A were from Radix Aconiti Kusnezoffii.
The total carbohydrate, uronic acid, protein, starch contents and yield of each polysaccharide fraction were listed in Table 1 . It was appeared that the water-soluble polysaccharides accounted for 9.93% of Radix Aconiti dry weight, 15.25% of Radix Aconiti Lateralis dry weight and 5.86% of Radix Aconiti Kusnezoffii dry weight. The starch contents of the water-soluble polysaccharides from Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii were respectively 54.98%, 73.90% and 71.84%. Due to the process of removing protein by Sevag method, the protein contents of polysaccharide fractions were all below 1.2%.
The results of monosaccharide compositions, molecular weight distributions (Table 2 ) and FT-IR analyses (characteristic absorbance of polysaccharides at 1650, 1400 and 1250 cm -1 ; α-D-glucan appeared at around 850 and 920 cm -1 ) indicated the water-soluble polysaccharides of Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii were all mainly composed of starch, non-starch type α-D-glucans and pectic polysaccharides. In Radix Aconiti, the ratio of starch, non-starch type α-D-glucans and pectic polysaccharides was 7.9:3.5:1.0, the molecular weights of non-starch type α-D-glucans were 302.9-10.8 and 10.0 kD in the ratio of 1.0:1.5, and molecular weights of pectic polysaccharides were ≥1000, 199.7, 160.2, 13.0 and 10.8 kD in the ratio of 1.0:1.6:0.7:1.0:1.4.
In Radix Aconiti Lateralis, the ratio of starch, nonstarch type α-D-glucans and pectic polysaccharides was 12.5:3.0:1.0, the molecular weights of non-starch type α-D-glucans were 13.3 and 10.2 kD in the ratio of 1.0:7.9, and molecular weights of pectic polysaccharides were ≥1000, 207.3, 160.2, 10.2 and 5.8 kD in the ratio of 1.6:1.6:1.1:1.3:1.0.
In Radix Aconiti Kusnezoffii, the ratio of starch, nonstarch type α-D-glucans and pectic polysaccharides was 8.9:2.2:1.0, the molecular weights of non-starch type α-D-glucans were 113.4-10.2 and 9.6 kD in the ratio of 1.0:2.5, and molecular weights of pectic polysaccharides were ≥1000, 169.6, 160.2, 12.4 and 8.8 kD in the ratio of 1.0:4.5:2.6:5.8:1.6. Data were reported as mean±SD (n = 10). IR: inhibitory rate; Thymus index: Thymus weight/body weight; Spleen index: spleen weight/body weight; WBC: white blood cell. Cy: Cyclophosphamide (positive drug). Significant differences compared with the Model, a P < 0.001, b P < 0.01 and c P < 0.05.
Some starch type polysaccharides from medicinal plants were reported to have strong antitumor and immunological activities [10] [11] [12] [13] . However, the polysaccharides' immunomodulatory effects and anticancer activity are influenced by the chain length, branch-point number, molecular size and tertiary structure [14] . So the starch type polysaccharides from Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii will be purified to be homogenous fractions to do the structure-activity relationship research in future study.
The present study investigated the antitumor activities of the non-starch type polysaccharide fractions using murine hepatoma 22 (H22) bearing mice. As shown in Table 3 , the tumor growth inhibition ratios (IR) of polysaccharide fractions were 37.24-70.42%, indicating that all fractions had remarkable antitumor activities. To compare the IR values, monosaccharide compositions and molecular weights of the polysaccharide fractions, we deduced that the contents of galacturonic acid and arabinose, and the molecular weight distributions influenced the antitumor activities in the present experimental conditions: the fractions with larger amount of galacturonic acid and arabinose, and higher molecular weights showed higher antitumor activities [15] [16] [17] .
As a tumor grows progressively, the immune system of tumor-bearing host is frequently impaired [18, 19] . Cyclophosphamide (Cy) is the most widely used alkylation agent in tumor chemotherapy nowadays. The tumor growth inhibited effect of Cy is in proportion to the administered dose, often resulting in immunosuppressive and cytotoxic effects, which is a major limited factor in clinical chemotherapy with efficacious remedies [20, 21] . That was coincident with the thymus index, the spleen index and WBC count of Cy treated tumor-bearing mice, shown in Table 3 . The Cy-treatment, especially the high dose of Cy-treatment, markedly reduced the weights of immune organs and the number of peripheral white blood cells. To compare with the model group, treatments with all the fractions from Aconitum species could restore the thymus index, the spleen index and the number of peripheral WBC in tumor-bearing mice, and no signs of overt toxicity were observed in the polysaccharide-treated mice on base of bodyweight (data not shown) monitored on day 8. Plant polysaccharides exert their antitumor action mostly via activation of the immune response of the host organism, which are regarded as biological response modifiers (BRMs) [22] . They can restore the tumor-destroyed immune system close to normal level, including the thymus index, the spleen index and the WBC count [23] . Some studies revealed that the increased WBC number by polysaccharides treatment were attributed to increases in monocytes, neutrophils and a decrease of apoptosis in peripheral lymphocytes [24, 25] . Base on the above results, we deduced that the antitumor effects of the polysaccharide fractions were attributed to their immunomodulating activities and the increases in monocytes, neutrophils and a decrease of apoptosis in peripheral lymphocytes by treatment with polysaccharide fractions led to the increase in WBC count in tumor-bearing mice.
To confirm the immunostimulating activity and the ability of ameliorating the immunosuppressive effect induced by the antitumor agent Cy, all the polysaccharide fractions were tested in assays for phagocytosis of macrophages, NK cell activity, lymphocyte proliferation, quantitative haemolysis of SRBC (QHS) and delayedtype hypersensitivity (DTH) reaction, using Cy-induced immunosuppressed mice.
The present results show that 100 mg/kg Cy significantly induced decreases in phagocytosis of macrophages, NK cell activity, concanavalin A (ConA)-induced T-cell proliferation, lipopolysaccharide (LPS)-induced B-cell proliferation, QHS and DTH reaction, respectively, which in combination had a high degree of concordance with the predicted immunotoxic properties of antitumor drugs [26] . The model group was only treated with normal saline, after receiving cyclophosphamide (Cy) at a dose of 100 mg/kg body weight in succession for 5 days. Data were reported as mean±SD (n = 10). Significant differences compared with the model group were designated as a P < 0.001, b P < 0.01 or c P < 0.05.
Macrophages, an integral part of the immune system, play an important role in the initiation and regulation of the immune response by interacting with lymphocytes, and acting as phagocytic, microbiocidal and tumoricidal effector cells [27] . As shown in Table 4 , all the fractions, specifically the neutral fractions, significantly increased the phagocytosis index and the phagocytosis coefficient, indicating that all the fractions could activate macrophages and restore phagocytosis activity in Cy-treated mice. Besides macrophage phagocytosis, another important function for the nonspecific immune system is NK cytotoxic activity. As shown in Figure 1 , the values for cytotoxicity of the polysaccharide treated groups were significantly increased compared with the model group, especially for the pectic fractions with the higher galacturonic acid and arabinose contents and higher molecular weights.
Lymphocyte proliferation is a crucial event in the activation cascade of both cellular and humoral immune responses [28] . As shown in Figure 2 , it was observed that all the fractions significantly augmented lymphocyte proliferation induced by either ConA or LPS in Cy-induced mice. Moreover, the neutral fractions showed stronger abilities to augment T lymphocyte proliferation and the pectic fractions showed stronger abilities to augment B lymphocyte proliferation.
Polysaccharide fractions were also assessed for their immunopotential activities by the levels of SRBCinduced antibody production and DTH reaction. As shown in Figure 3 and Table 4 , the anti-SRBC antibody production and DTH reaction in immunosuppressive mice were markedly promoted by all fractions. Specifically, the pectic fractions could restore the levels of antibody production close to normal. The results of QHS and DTH assays suggested that non-starch type polysaccharides from Aconitum species could block the inhibition of T cell and B cell function caused by Cy in mice.
Summarizing the above results, all the non-starch type polysaccharide fractions could inhibit tumor growth, enhance and restore the Cy-suppressed immune function, including nonspecific immunity, cellular immunity and humoral immunity. Moreover, the pectic polysaccharides showed more remarkable antitumor and immunostimulating activities than the neutral polysaccharides.
Therefore, as a novel medicinal source, the polysaccharides from the root of Aconitum species, especially the pectic polysaccharides, were good immune stimulating modifiers and had the potential to apply in the tumor therapy. However, the structures of the obtained polysaccharides were not clear, so were the structure-activity relationships. All of these contents have been on process. General methods: The total carbohydrate content was determined by phenol-H 2 SO 4 method using glucose as standard [29] . All gel filtration chromatography was monitored by assaying carbohydrate content. Uronic acid content was determined by m-hydroxydiphenyl colorimetric method, using galacturonic acid as standard [30] . Protein content was determined by the method of Sedmak and Grossberg [31] , with Coomassie brilliant blue reagent and bovine serum albumin as the standard. Starch content was determined according to the method of Gur et al. [32] , using soluble starch as the standard. Dialysis was carried out using tubing with Mw cut-off 3,500 Da (for globular protein).
Experimental

Materials and chemicals: Radix
UV-Vis absorbance spectra were recorded with a UV-Vis spectro-photometer (Model SP-752, China). HPLC was carried out on a Shimadzu 10Avp HPLC system equipped with 10Avp HPLC Pump, SPD-10Avp UV-VIS detector. FT-IR spectra were obtained on a Nicolet 560 FT-IR spectrometer with DTGS detector in a range of 400-4000 cm -1 . The samples were measured as a film on KBr discs.
Extraction and fractionation:
Materials were dried and ground, and then exhaustively extracted with 95% ethanol under reflux for 12 h to remove hydrophobic compounds. This step was repeated three times. After filtration through a gauze (100 mesh), the residue was dried at room temperature, and then extracted with cold water (4°C, 1:20 w/v) three times (6 h for each). The aqueous filtrates were combined and concentrated, subsequently 95% ethanol was added to the aqueous filtrates up to 80% to precipitate the polysaccharides which were collected by centrifugation and dried in vacuum. The precipitate was dissolved in water (5% w/v) and removed the insoluble substances by centrifugation. The supernatant was treated with Sevag reagent (1:4 of n-butanol:chloroform, v/v) to remove free proteins. After removing the remaining Sevag reagent by vacuum evaporation, the water phase was freeze-dried, giving rise to polysaccharide CWP (cold water extracted polysaccharides). CWP was dissolved in water (5% w/v) and submitted to freeze-thawing process, centrifuged to remove the precipitate, the supernatant (CWPS) was further fractionated by DEAE-Sepharose Fast Flow ion-exchange chromatography, eluted with distilled water and 0.5 M NaCl in turn, generating two fractions: CWPS-N and CWPS-A. Meanwhile, the cold water extracted residue was extracted by water at 95°C and the obtained polysaccharides were purified and fractionated following the above procedure, resulting in fraction HWP (hot water extracted polysaccharides), HWPS, HWPS-N and HWPS-A. Finally, the water-soluble polysaccharides were fractionated into 4 fractions of each material: the fractions A-CWPS-N, A-CWPS-A, A-HWPS-N and A-HWPS-A were from Radix Aconiti; the fractions L-CWPS-N, L-CWPS-A, L-HWPS-N and L-HWPS-A were from Radix Aconiti Lateralis; the fractions K-CWPS-N, K-CWPS-A, K-HWPS-N and K-HWPS-A were from Radix Aconiti Kusnezoffii. Contaminant endotoxin was analyzed by a gel-clot Limulus amebocyte lysate assay. The endotoxin level in each polysaccharide solution was less than 0.5 EU (endotoxin units)/mL [33] .
Determination of the molecular weight distribution:
The molecular weight distributions were determined by gel filtration chromatography. Sample (5 mg) was dissolved in 0.15 M NaCl (0.5 mL), and the solution was applied to a column of Sepharose CL-6B (85 cm × 1.5 i.d.), eluting with 0.15 M NaCl at a flow rate of 0.15 mL/min. The gel filtration column was calibrated by standard dextrans (12 kD, 50 kD, 150 kD, 470 kD and 670 kD) using linear regression.
Monosaccharide component analysis:
The monosaccharide component analysis was performed by HPLC method as described by Honda et al. [34] and Yang et al. [35] . Briefly, the sample (2 mg) was first methanolyzed using 0.5 mL anhydrous methanol containing 2 M HCl at 80°C for 16 h. Then the methanolyzed products were hydrolyzed with 0.5 mL 2 M CF 3 COOH at 120°C for 1 h [36] . The hydrolysisproduct monosaccharides were derivatized to be 1-phenyl-3-methyl-5-pyrazolone (PMP) derivatives and subsequently analyzed by HPLC on a Shim-pak VP-ODS column (150 × 4.6 mm i.d.) with a guard column on a Shimadzu HPLC system and monitored by UV absorbance at 245 nm.
Antitumor activity of Aconitum polysaccharides in vivo:
Under sterile condition, 0.2 mL of H22 cell suspension (5 × 10 6 cells/mL) was implanted subcutaneously at the right groins of mice respectively on day 0. After 24 h of inoculation, mice were weighed, and randomly divided into 15 groups of 10 mice each. The 12 polysaccharide fractions were dissolved in sterile normal saline and administered intraperitoneally at a dose (0.2 mL) of 100 mg/kg/d for 7 days, respectively. On day 8, the mice were weighed and blood samples were collected from the orbital vein. The number of the peripheral white blood cells (WBC) was counted with an inverted microscope. Then the mice were sacrificed, and the tumor, thymus and spleen were dissected and weighed. Antitumor activity was evaluated by tumor growth inhibition ratio (IR %) = [(TW control -TW treatment ) / TW control ] × 100, where TW control is the weight of untreated tumor and TW treatment is the weight of treated tumor. The weights of thymus and spleen were used to calculate the thymus index and the spleen index, respectively [37] .
Cy-treatment and drug administration: ICR mice were randomly divided into 14 groups of 10 mice each. Before the treatment, all animals received Cy intraperitoneally at a dose of 100 mg/kg body weight in succession for 5 days to establish the immunosuppressive animal model, except the normal group. Subsequently, the mice in treatment groups were treated intraperitoneally with different polysaccharide fractions at a dose (0.2 mL) of 100 mg/kg/d for 10 days, respectively.
Preparation of spleen cell suspension:
The spleens were removed and minced in sterile plates containing Hank's balanced salt solution (HBSS). Suspensions were further gently pressed through a 200 mesh metal sieve to remove major tissue aggregates. The erythrocytes were lyzed with haemolysed solution (7 g/L NH 4 Cl and 2.6 g/L Tris-HCl) and removed by centrifugation (180 × g, 10 min). Then the spleen cells were suspended in 1 mL RPMI-1640 complete medium with 10% (v/v) FBS, 100 U/mL of penicillin and 0.1 mg/mL of streptomycin. Cell viability was assessed by the trypan blue exclusion method.
Phagocytosis of macrophage assay:
Twenty-four hours after the last administration, mice were injected with 0.1 mL of carbon suspension (India ink, 1:5 dilutions by normal saline) through the tail vein. 20 µL of blood were taken from the orbital vein at 1 (t 1 ) and 5 (t 5 ) min after injection, and lyzed with 2 mL of 0.1% Na 2 CO 3 immediately, then measured for absorbance at 680 nm against the 0.1% Na 2 CO 3 solution blank. Subsequently, mice were weighed, sacrificed and the total weight of the liver and spleen was estimated. The phagocytosis index (k) and the phagocytosis coefficient (α) were calculated according to the following equations: k = (log A 1 − log A 5 ) / (t 5 − t 1 ); α = k 1/3 × body weight (g) / the total weight of the liver and spleen (g), where A 1 and A 5 are the absorbance values of the blood-Na 2 CO 3 mixtures at 680 nm for the blood samples collected at 1 (t 1 ) and 5 (t 5 ) min, respectively [38] .
NK cell activity assay:
Splenocyte suspension was prepared and adjusted to a concentration of 1 × 10 7 cells/mL, then 100 µL of splenocytes (effector cells, E) suspension and 100 µL of YAC-1 cells at a concentration of 1 × 10 5 cells/mL (target cells, T) were mixed in a same well of 96-well round-bottom plates, resulting in E:T ratio of 100:1. The spontaneous release and the maximum release were determined by adding 100 µL of medium and Triton X-100 (2.5%) to each well containing the target cells, respectively. Following a 4-h incubation at 37°C in a humidified 5% CO 2 incubator, the plates were centrifuged (400 × g, 5 min), and 100 µL of the supernatants were removed to another plate, then 100 µL of lactate dehydrogenase (LDH) substrate mixtures (pH 8.2, natrium lacticum, INT, PMS and NAD + dissolved in 0.2 M Tris-HCl buffer to yield final concentration of 5 × 10 -2 , 6.6 × 10 -4 , 2.8 × 10 -4 and 1.3 × 10 -3 M, respectively) were added. The absorbance (A) of the reaction product was evaluated in an ELISA reader (Model 680, Bio-Rad Instruments) at 490 nm. NK cell activity was evaluated by the following equations: where A experimental is the absorbance value of LDH released from coculture of effector and target cells. A spontaneous and A maximum are the absorbance values of LDH released spontaneously from YAC-1 cells and YAC-1 cells lyzed by 2.5% Triton, respectively [39] .
Lymphocyte proliferation assay: Splenocyte suspension was prepared and adjusted to a concentration of 5 × 10 6 cells/mL, and an aliquot of 100 µL of splenocytes suspension was seeded into each well of a 96-well plate in the presence of ConA (5 µg/mL) or LPS (10 µg/mL). After preincubation for 48 h at 37°C in a humidified 5% CO 2 incubator, 10 µL of 0.4% MTT was added into each well. The plates were incubated for another 4 h, and then the solution was dissolved in Me 2 SO (100 µL/well) and measured A 570 nm [40] .
Quantitative haemolysis of SRBC (QHS) assay:
Mice in all groups were initially sensitized by 0.2 mL of 10% SRBC suspension on day 11. Five days later, the splenocyte suspension of 1 × 10 6 cells/mL prepared in PBS were incubated at 37°C for 1 h after mixing with 1 mL of 0.2% SRBC and 1 mL of 10% guinea pig serum complement. After centrifugation at 3000 rpm for 3 min, the extent of hemolysis of SRBC in the supernatant was determined at 413 nm [41] .
DNFB-induced delayed-type hypersensitivity (DTH) response:
Mice were initially sensitized by applying 50 µL of 1% DNFB in mixed acetone-olive oil (4:1, v/v) on the shaved abdominal skin on day 11. Five days later, the DTH reaction was elicited by smearing 10 µL 1% DNFB on both sides of the left earlap of mice. Twenty-four hours after challenge, the DTH response was evaluated by the weight difference between the right and left ear patch (9 mm) [42] .
Statistical analysis:
The data were reported as mean ± standard deviation (SD). One-way ANOVA analysis of variance and Student's t-tests were conducted to identify differences among means. Statistical significance was declared at P < 0.05.
